Featured
Urban mouse allergens worsen childhood asthma risks
Drug Approvals Nov 7, 2026
Vaccine News Nov 6, 2026
Clinic Moves Nov 5, 2026
People with disabilities may face higher substance misuse risk due to chronic pain and multiple...
Researchers study synthetic growth hormone stimulator to understand its effects on growth hormone secretion.
Checkpoint immunotherapy may reshape melanoma-involved lymph nodes, reorganizing cell types and altering macrophage behavior, Mayo...
Read our latest Drug Approvals articles.
Urban mouse allergens may worsen childhood asthma symptoms, embedding in household dust and triggering reactions...
Mayo Clinic develops a real-time airborne pathogen detection system that could transform indoor biological threat...
Personalized breast cancer screening guidelines are replacing one-size-fits-all approaches, offering tailored plans based on individual...
Standard physical tests often fail to diagnose chronic pelvic pain effectively. Learn how brain processing and inflammation play a larger role in diagnosis and
Standard physical tests often fail to diagnose chronic pelvic pain effectively. Learn how brain processing and inflammation play a larger...
Scientists suggest boosting glutathione may slow age-related cellular decline, offering one of the most promising approaches to support long-term health.
Family physicians weigh multiple factors when deciding whether to refer a patient for a hearing assessment, including symptoms and access...
Tirzepatide and semaglutide have similar asthma risks in adults with type 2 diabetes and asthma.
FDA reviews two novel ADHD drug candidates in late-stage development, offering new approaches to treatment.
Doctors reject federal vaccine changes lacking scientific backing as top medical groups like AAP and ACOG defend evidence-based immunization schedules.
Effective strategies for managing challenging patient relationships, focusing on cases where patients reject care or question competence.
The FIB-4 index celebrates 20 years as a non‑invasive tool for spotting advanced liver fibrosis in MASLD, MASH, hepatitis C...
New ATA guidelines for thyroid disease in pregnancy and preconception provide expert updates on testing, hypothyroidism, and iodine intake for...
Noninvasive tests now replace risky liver biopsies for diagnosing metabolic dysfunction-associated steatohepatitis (MASH) and MASLD, offering safer, cost-effect